PHARMAPACK Trademark

Trademark Overview

On Tuesday, October 10, 2017, a trademark application was filed for PHARMAPACK with the United States Patent and Trademark Office. The USPTO has given the PHARMAPACK trademark a serial number of 87639500. The federal status of this trademark filing is REGISTERED as of Tuesday, August 24, 2021. This trademark is owned by IMPRIMIS PHARMACEUTICALS, INC.. The PHARMAPACK trademark is filed in the Medical Instrument Products category with the following description:

Medical kits comprising compounded pharmaceutical formulations for ophthalmological applications and surgical instruments and devices for administering the compounded pharmaceutical formulations to patients prior to, during, or following ophthalmological surgical procedures
pharmapack

General Information

Serial Number87639500
Word MarkPHARMAPACK
Filing DateTuesday, October 10, 2017
Status700 - REGISTERED
Status DateTuesday, August 24, 2021
Registration Number6463822
Registration DateTuesday, August 24, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 22, 2018

Trademark Statements

Goods and ServicesMedical kits comprising compounded pharmaceutical formulations for ophthalmological applications and surgical instruments and devices for administering the compounded pharmaceutical formulations to patients prior to, during, or following ophthalmological surgical procedures

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, October 17, 2017
Primary Code010
First Use Anywhere DateSaturday, September 30, 2017
First Use In Commerce DateSaturday, September 30, 2017

Trademark Owner History

Party NameHARROW IP, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressNASHVILLE, TN 37205
Party NameHARROW IP, LLC
Party Type22 - New Owner After Publication
Legal Entity Type16 - Limited Liability Company
AddressNASHVILLE, TN 37205
Party NameHARROW HEALTH, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressSAN DIEGO, CA 92130
Party NameIMPRIMIS PHARMACEUTICALS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130
Party NameIMPRIMIS PHARMACEUTICALS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Trademark Events

Event DateEvent Description
Wednesday, April 12, 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, August 24, 2021REGISTERED-PRINCIPAL REGISTER
Wednesday, July 21, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, July 20, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, July 19, 2021STATEMENT OF USE PROCESSING COMPLETE
Wednesday, July 14, 2021USE AMENDMENT FILED
Wednesday, July 14, 2021TEAS STATEMENT OF USE RECEIVED
Thursday, March 25, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 24, 2021SOU EXTENSION 5 GRANTED
Tuesday, January 19, 2021SOU EXTENSION 5 FILED
Tuesday, March 23, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, January 20, 2021NOTICE OF REVIVAL - E-MAILED
Wednesday, January 20, 2021EXTENSION RECEIVED WITH TEAS PETITION
Wednesday, January 20, 2021PETITION TO REVIVE-GRANTED
Wednesday, January 20, 2021TEAS PETITION TO REVIVE RECEIVED
Wednesday, December 16, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 16, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, December 16, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 27, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 27, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, October 27, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, September 14, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, September 14, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, September 14, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, September 14, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, July 4, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 2, 2020SOU EXTENSION 4 GRANTED
Thursday, July 2, 2020SOU EXTENSION 4 FILED
Thursday, July 2, 2020TEAS EXTENSION RECEIVED
Wednesday, January 8, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 6, 2020SOU EXTENSION 3 GRANTED
Monday, January 6, 2020SOU EXTENSION 3 FILED
Monday, January 6, 2020TEAS EXTENSION RECEIVED
Wednesday, November 6, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, July 17, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 15, 2019SOU EXTENSION 2 GRANTED
Monday, July 15, 2019SOU EXTENSION 2 FILED
Monday, July 15, 2019TEAS EXTENSION RECEIVED
Wednesday, January 16, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Saturday, January 5, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 3, 2019SOU EXTENSION 1 GRANTED
Thursday, January 3, 2019SOU EXTENSION 1 FILED
Thursday, January 3, 2019TEAS EXTENSION RECEIVED
Tuesday, July 17, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 22, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 22, 2018PUBLISHED FOR OPPOSITION
Wednesday, May 2, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, April 14, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 13, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 13, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 13, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, November 8, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, November 8, 2017NON-FINAL ACTION E-MAILED
Wednesday, November 8, 2017NON-FINAL ACTION WRITTEN
Thursday, October 26, 2017ASSIGNED TO EXAMINER
Tuesday, October 17, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Related Keywords

pharmapack formulations ophthalmological pharmaceutical surgical compounded patients prior during procedures following